Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02332070 · ClinicalTrials.gov registry record
Timing of Coronary Angiography, Cardiac Surgery, and Adverse Renal and Cardiac Events (MARCE)
A clinical trial, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 965
- Enrollment target
NCT02332070 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 965 participants.
The verdict
NCT02332070 has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 965 participants
- Enrollment target
Study Summary
1. To examine two main predictor variables independently and then jointly in stratified and multivariate analyses for the outcomes of CSA-AKI, MARCE, need for RRT, and inpatient mortality, and the composite, as well as the outcomes of 30 day rehospitalization or death, and finally for the days out of hospital and alive adjusted to person-year of time 1. Days from coronary angiogram performed with IOCM to cardiac surgery (1, 2, 3, etc) 2. Thakar Acute Renal Failure (ARF) score (1 to 17) 2. To examine the interrelationships between time in days between angiogram and surgery and the ARF Score with the Society of Thoracic Surgery (STS) Risk score for mortality
Interventions
- PROCEDURE cardiac surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 965 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02332070
The ClinicalTrials.gov registry entry for NCT02332070 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 965 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cardiac surgery is the first listed.
NCT02332070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02332070 about?
NCT02332070 is a clinical study titled "Timing of Coronary Angiography, Cardiac Surgery, and Adverse Renal and Cardiac Events (MARCE)". 1. To examine two main predictor variables independently and then jointly in stratified and multivariate analyses for the outcomes of CSA-AKI, MARCE, need for RRT, and inpatient mortality, and the composite, as well as the outcomes of 30 day rehospitalization or death, and finally for the days out o...
What is the current status of trial NCT02332070?
This trial is currently completed. The enrollment target is 965 participants. The study started on 2015-01. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02332070?
The interventions under investigation include: cardiac surgery (PROCEDURE).
Who is sponsoring clinical trial NCT02332070?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.